Why Brazil’s historic dengue outbreak has no near end in sight
Brazil's public vaccination campaign against dengue is unlikely to halt the disease's spread, according to experts.
Botswana lab known for identifying Omicron variant receives new recognition
When the lab of the Botswana Harvard AIDS Institute Partnership produced the first genetic sequence of the Omicron variant of the coronavirus in fall 2021, the world took notice. More recognition came last month when the lab was…
Rising dengue cases disproportionately affect children in U.S. territories
In U.S. territories in the Caribbean, cases of dengue are on the rise in children because of inequities in the effects of climate change and the accessibility of vaccines, according to experts.
Ukraine’s humanitarian crisis
Russia’s invasion of Ukraine has prompted a massive humanitarian crisis, with mounting military and civilian casualties and more than two million people on the move to escape the violence. In this Big 3 Q&A, Michael VanRooyen, director of…
We rely on fossil fuels—but ‘they’re killing us’
Air pollution is killing almost 8.8 million people each year—more annual deaths than tobacco smoking, HIV, and vector-borne illnesses such as malaria and dengue, according to a new study from a European research team. The authors of the…
A tech-centric approach to reducing mosquito-borne diseases
Hyegi Chung, MPH ’18, and former Harvard Chan postdoc Evdoxia Kakani met with students to talk about their work at Verily—a subsidiary of Alphabet, the parent company of Google—on using a tech-centric approach to reduce mosquito-borne diseases.
Harvard Chan student and alum help develop global vaccine access strategy
A DrPH student at Harvard T.H. Chan School of Public Health and a recent graduate of the program are helping pharmaceutical company Takeda develop strategies for bringing vaccines for infectious diseases like dengue, polio, and Zika to the…
